
TECHNICAL ARTICLES
相关文章

●Purchase●DescriptionTemsirolimus,arapamycin(sirolimus)derivative,alsoknownasCCI-779,isanmTORinhibitorwithanti-canceractivity
产品型号:27024
厂商性质:生产厂家
更新时间:2023-12-19
访 问 量:280
立即咨询
联系电话:
Temsirolimus, a rapamycin (sirolimus) derivative, also known as CCI-779, is an mTOR inhibitor with anti-cancer activity. Temsirolimus down-regulated the mTOR signaling intermediate phospho-S6 in xenografted human ALL. Temsirolimus has been shown to reverse cisplatin resistance in small cell lung cancer cell lines selected for cisplatin resistance and in cell lines derived from patients who failed cisplatin therapy.